Viewing Study NCT06668103


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2025-12-29 @ 1:23 AM
Study NCT ID: NCT06668103
Status: RECRUITING
Last Update Posted: 2024-12-12
First Post: 2024-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module